跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PROBUPHINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PROBUPHINE
Authorized
STANDARD
PROBUPHINE
knight therapeutics inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
80bc7fd6a89edf2e
Company
knight therapeutics inc.
Type
Standard
Approval Details
Approval Id
80bc7fd6a89edf2e
Drug Approval Canada Name
PROBUPHINE
Product Name
PROBUPHINE
Status
Cancelled Post Market
Status Date
2023-06-30
Original Market Date
2018-11-22
Din
02474921
Drug Class
Human
Dosage Form
Implant
Route Of Administration
Subcutaneous
Schedule
Narcotic (CDSA I)
Ahfs
28:08.12
Atc Original
N07BC01 BUPRENORPHINE
Atc Name
n 07 bc 01
Aig Number
0126788005
Company Name
knight therapeutics inc.
Company Address
1055, 3400 De Maisonneuve Blvd W, Montreal, Quebec, Canada, H3Z 3B8
Active Ingredients
BUPRENORPHINE HYDROCHLORIDE
80 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
80bc7fd6a89edf2e
Type
Standard
Back to Health Canada Approvals